Derivation of normal macrophages from human embryonic stem (hES) cells for applications in HIV gene therapy

Retrovirology

Volumn 3, Issue , 2006, Pages

  Anderson, Joseph S ^a   Bandi, Sriram ^a   Kaufman, Dan S ^b   Akkina, Ramesh ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD4 ANTIGEN; CELL SURFACE MARKER; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CYTOKINE; GREEN FLUORESCENT PROTEIN; HLA DR ANTIGEN; LENTIVIRUS VECTOR; LIPOPOLYSACCHARIDE; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CD34 SELECTION; CELL BASED GENE THERAPY; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; DRUG TARGETING; EMBRYONIC STEM CELL; FETUS LIVER; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSDUCTION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; STROMA CELL; TRANSGENE; UPREGULATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIGENS, CD; ANTIGENS, CD34; CELL DIVISION; CELL LINE; CULTURE MEDIA; EMBRYO, MAMMALIAN; GENE DELETION; GENETIC THERAPY; HIV INFECTIONS; HLA-DR ANTIGENS; HUMANS; MACROPHAGES; STEM CELLS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS;

EID: 33646799733     PISSN: 17424690     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-3-24     Document Type: Article

References (58)

1. Weissman I: Stem Cell Research: Paths to cancer therapies and regenerative medicine. JAMA 2005, 294:1359-1366.
2. Lerou PH, Daley GQ: Therapeutic potential of embryonic stem cells. Blood Rev 2005, 19:321-331.
3. Menendez P, Wang L, Bhatia M: Genetic manipulation of human embryonic stem cells: A system to study early human development and potential therapeutic applications. Curr Gene Ther 2005, 5:375-385.
4. D'Amour KA, Agulnick AD, Eliazar S, Kelly OG, Kroon E, Baetge EE: Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 2005, 23:1534-1541.
5. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM: Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
6. Kim HS, Oh SK, Park YB, Ahn HJ, Sung KC, Kang MJ, Lee LA, Suh CS, Kim SH, Kim DW, Moon SY: Methods for derivation of human embryonic stem cells. Stem cells 2005, 23:1228-1233.
7. Moon SY, Park YB, Kim D-S, Oh SK, Kim D-W: Generation, culture, and differentiation of human embryonic stem cells for therapeutic applications. Mol Ther 2005, 13:5-14.
8. Pera MF, Trounson AO: Human embryonic stem cells: prospects for development. Development 2004, 131:5515-5525.
9. Keller G: Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev 2005, 19:1129-1155.
10. Weiss RA: HIV and AIDS: Looking ahead. Nat Med 2003, 9:887-891.
11. Pomerantz RJ, Horn DL: Twenty years of therapy for HIV infection. Nat Med 2003, 9:867-873.
12. Strayer DS, Akkina R, Bunnell BA, Dropulic B, Planelles V, Pomerantz RJ, Rossi JJ, Zaia JA: Current status of gene therapy strategies to treat HIV/AIDS. Mol Ther 2005, 11:823-842.
13. Akkina R, Banerjea A, Bai J, Anderson J, Li MJ, Rossi J: siRNAs, Ribozymes, and RNA Decoys in Modeling Stem Cell-based Gene Therapy for HIV/AIDS. Anticancer Res 2003, 23:1997-2005.
14. Michienzi A, Castanotto D, Lee N, Li S, Zaia JA, Rossi JJ: RNA-mediated inhibition of HIV in a gene therapy setting. Ann NY Acad Sci 2003, 1002:63-71.
15. Berger EA, Murphy PM, Farber JM: Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 1999, 17:657-700.
16. Anderson J, Akkina R: CXCR4 and CCR5 shRNA transgenic CD34+ cell derived macrophages are functionally normal and resist HIV-1 infection. Retrovirology 2005, 2:53.
17. Anderson J, Akkina R: TRIM5alpha(rh) expression restrictsHIV-1 infection in lentiviral vector-transduced CD34(+)-cell-derived macrophages. Mol Ther 2005, 12:687-696.
18. Li MJ, Kim J, Li S, Zaia J, Yee JK, Anderson J, Akkina R, Rossi JJ: Long-Term Inhibition of HIV-1 Infection in PrimaryHematopoietic Cells by Lentiviral Vector Delivery of a TripleCombination of Anti-HIV shRNA, Anti-CCR5 Ribozyme, and a Nucleolar-Localizing TAR Decoy. Mol Ther 2005, 12:900-909.
19. Verfaillie CM: Hematopoietic stem cells for transplantation. Nat. Immunol 2002, 3:314-317.
20. Kaufman DS, Hanson ET, Lewis RL, Auerbach R, Thomson JA: Hematopoietic colony-forming cells derived from humanembryonic stem cells. Proc Natl Acad Sci USA 2001, 98:10716-10721.
21. Vodyanik MA, Bork JA, Thomson JA, Slukvin II: Human embryonic stem cell-derived CD34+ cells: efficient production in the coculturewith OP9 stromal cells and analysis of lymphohematopoietic potential. Blood 2005, 105:617-626.
22. Qiu C, Hanson E, Olivier E, Inada M, Kaufman DS, Gupta S, Bouhassira EE: Differentiation of human embryonic stem cells into hematopoietic cell by coculture with human fetal liver cells recapitulates the globin switch that occurs early in development. Exp Hematol 2005, 33:1450-1458.
23. Wang L, Menendez P, Shojaei F, Li L, Mazurier F, Dick JE, Cerdan C, Levac K, Bhatia M: Generation of hematopoietic repopulating cells from human embryonic stem cells independent of ectopic HOXB4 expression. J Exp Med 2005, 201:1603-1614.
24. Chadwick K, Wang L, Li L, Menendez P, Murdoch B, Rouleau A, Bhatia M: Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 2003, 102:906-915.
25. Wang L, Li L, Menendez P, Cerdan C, Bhatia M: Human embryonic stem cells maintained in the absence of mouse embryonic fibroblasts or conditioned media are capable of hematopoietic development. Blood 2005, 105:4598-4603.
26. Lu SJ, Li F, Vida L, Honig GR: CD34+/CD38-hematopoietic precursors derived from human embryonic stem cells exhibit an embryonic gene expression pattern. Blood 2004, 103:4134-4141.
27. Martin CH, Kaufman DS: Synergistic use of adult and embryonic stem cells to study human hematopoiesis. Curr Opin Biotechnol 2005, 16:1-6.
28. Woll PS, Martin CH, Miller JS, Kaufman DS: Humanembryonic stem cell-derived NK cells acquire functional receptors and cytolytic activity. J Immunol 2005, 175:5O95-5103.
29. Zhan X, David G, Ye Z, Hammond H, Shamblott M, Gearhart J, Cheng L: Functional antigen-presenting leucocytes derived from human embryonic stem cells in vitro. Lancet 2004, 364:163-171.
30. Ma Y, Ramezani A, Lewis R, Hawley RG, Thomson JA: High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Stem cells 2003, 21:111-117.
31. Gropp M, Itsykson P, Singer O, Ben-Hur T, Reinhartz E, Galun E, Reubinoff BE: Stable genetic modification of human embryonic stem cells by lentiviral vectors. Mol Ther 2003, 7:281-287.
32. Suter DM, Cartier L, Bettiol E, Tirefort D, Jaconi ME, Dubois-Dauphin M, Krause KH: Rapid generation of stable transgenic embryonic stem cell lines using modular lentivectors. Stem cells 2005 in press.
33. Pfeifer A, Ikawa M, Dayn Y, Verma IM: Transgenesis bylentiviral vectors: lack of gene silencing in mammalian embryonic-stem cells and preimplantation embryos. Proc Natl Acad Sci U S A 2002, 99:2140-2145.
34. Bongso, A, Lee EH: Stem cells: From bench to bedside Hackensack: World Publishing Co; 2005.
35. Peled A, Petit I, Kollet O, Magid M, Ponomaryov T, Byk T, Nagler A, Ben-Hur H, Many A, Shultz L, Lider O, Alon R, Zipori D, Lapidot T: Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999, 283:845-848.
36. Cagnon L, Rossi J: Down regulation of the CCR5 beta-chemokine receptor and inhibition of HIV-1 infection by stable VAI-ribozymechimerical transcripts. Antisense Nucleic Acid Drug Dev 2001, 10:251-261.
37. Bahner I, Kearns K, Hao Q-L, Smogorzewska EM, Kohn DB: Transduction of human CD34+ hematopoietic progenitor cells bya retroviral vector expressing an RRE decoy inhibits human-immunodeficiency virus type 1 replication in myelomonocytic cellsproduced in long term culture. J Virol 1996, 70:4352-4360.
38. Bai J, Gorantla S, Banda N, Cagnon L, Rossi J, Akkina R: Characterization of Anti-CCR5 Ribozyme-Transduced CD34+Hematopoietic Progenitor Cells in Vitro and in a SCID-huMouse Model in Vivo. Mol Ther 2002, 1:244-254.
39. Bonyhadi ML, Moss K, Voytovich A, Auten J, Kalfoglou C, Plaveeec I, FFForstell S, Su L, Bohnlein E, Kaneshima H: RevM 10-expressing T cells derived in vivo from transducedhuman hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication. J Virol 1997, 71:4707-4716.
40. Banda N, Akkina RK, Terrell K, Shpall EJ, Tomczak J, Campai J, Clamam H, Cagle L, Harrison G: Diptheria toxin A gene-mediated HIV-1 protection of cord blood-derived T cells in the SCID-hu mouse model. Hematol J 1997, 7:319-331.
41. Coburn GA, Cullen BR: Potent and Specific Inhibition of Human Immunodeficiency Virus Type 1 Replication by RNA Interference. J Virol 2002, 76:9225-9231.
42. Jacque J, Triques K, Stevenson M: Modulation of HIV-1 replication by RNA interference. Nature 2002, 418:379-380.
43. Lee NS, Dohjima T, Bauer G, Li H, Li MJ, Ehsani A, Salvaterra P, Rossi J: Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotech 2002, 19:500-505.
44. Novina CD, Murray MF, Dyloxhoorn DM, Beresford PJ, Riess J, Lee SK, Collman RG, Lieberman J, Shankar P, Sharp PA: siRNA-directedinhibition of HIV-1 infection. Nat Med 2002, 8:681-686.
45. Qin XF, An DS, Chen IS, Baltimore D: Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc Natl Acad Sci USA 2003, 100:183-188.
46. Martinez MA, Gutierrez A, Armand-Ugon M, Blanco J, Parera M, Gomez J, Clotet B, Este JA: Suppression of chemokine receptorexpression by RNA interference allows for inhibition of HIV-1 replication. AIDS 2002, 16:2385-2390.
47. Zhou N, Fang J, Mukhtar M, Acheampong E, Pomerantz RJ: Inhibition of HIV-1 fusion by small interfering RNAs targeting the chemokine receptor CXCR4. Gene Ther 2004, 11:1703-1712.
48. Banerjea A, Li MJ, Bauer G, Remling L, Lee NS, Rossi J, Akkina R: Inhibition of HIV-1 by lentiviral vector-transduced siRNAs inlymphocytes diferentiated in SCID-hu mice and CD34+ progenitorcell-derived macrophages. Mol Ther 2003, 8:62-71.
49. Anderson J, Banerjea A, Akkina R: Bispecificshort-hairpin siRNA constructs targeted to CD4, CXCR4, and CCR5 confer HIV-1 resistance. Oligonucleotides 2003, 13:303-312.
50. Anderson J, Akkina R: HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector. AIDS Res Ther 2005, 2:1-12.
51. Kohn DB, Bauer G, Rice CR, Rothschild JC, Carbonaro DA, Valdez P, Hao Q, Zhou C, Bahner I, Kearns K, Brody K, Fox S, Haden E, Wilson K, Salata C, Dolan C, Wetter C, Aguilar-Cordova E, Church J: A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34(+) cells from the bone marrow of human immunodeficiency virus-1-infected children. Blood 1999, 94:368-371.
52. Braun SE, Wong FE, Connole M, Qiu G, Lee L, Gillis J, Lu X, Humeau L, Slepushkin V, Binder GK, Dropulic B, Johnson RP: Inhibition of simian/ human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells. Mol Ther 2005, 12:1157-1167.
53. Drukker M, Katchman H, Katz G, Even-Tov Friedman S, Shezen E, Hornstein E, Mandelboim O, Reisner Y, Benvenisty N: Humanembryonic stem cells and their differentiated derivatives are less susceptible for immune rejection than adult cells. Stem cells 2006 in press.
54. Narayan AD, Chase JL, Lewis RL, Tian X, Kaufman DS, Thomson JA, Zanjani ED: Human embryonic stem cell-derived hematopoietic cells are capable of engrafting primary as well as secondary fetal sheep recipients. Blood 2005 in press.
55. Kaufman DS, Woll PS, Martin CH, Linehan J, Tian X: CD34+ Cells Derived from Human Embryonic Stem Cells Demonstrate Hematopoietic Stem Cell Potential In Vitro and In Vivo [abstract]. Blood 2006, 104:a163.
56. Kaufman DS, Thomson JA: Human ES cells-haematopoiesis and transplantation strategies. J Anat 2002, 200:243-248.
57. Bradley JA, Bolton EM, Pedersen RA: Stem cell medicine encounters the immune system. Nat Rev Immunol 2002, 2:859-871.
58. Ramezani A, Hawley TS, Hawley RG: Performance-and safety-enhanced lentiviral vectors containing the human interferon-β scaffold attachment region and the chicken β-globin insulator. Gene Therapy 2003, 101:4717-4724.